Showing results (151-160 of 584) with videos related to

Sort By:
Pageof 59
European Journal of Cancer (Oxford, England : 1990)|January 30, 2021
Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non-small cell lung cancer treated with immunotherapyIthar Gataa, Laura Mezquita, Caroline Rossoni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 29, 2021
Phase 2 Study of Dabrafenib Plus Trametinib in Patients With BRAF V600E-Mutant Metastatic NSCLC: Updated 5-Year Survival Rates and Genomic AnalysisDavid Planchard, Benjamin Besse, Harry J M Groen, et al.
Cancers|October 3, 2020
Impact of Intercurrent Introduction of Steroids on Clinical Outcomes in Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients under Immune-Checkpoint Inhibitors (ICI)Andrea De Giglio, Laura Mezquita, Edouard Auclin, et al.
NPJ Precision Oncology|April 16, 2024
BRAF<sup>V600E</sup>-mutant metastatic NSCLC: disease overview and treatment landscapeDavid Planchard, Rachel E Sanborn, Marcelo V Negrao, et al.
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|July 29, 2015
Role of adjuvant radiotherapy in completely resected non-small-cell lung cancerCecile Le Péchoux, Olaf Mercier, Deborah Belemsagha, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 12, 2016
Moving Immune Checkpoint Blockade in Thoracic Tumors beyond NSCLCFrancesco Facchinetti, Aurélien Marabelle, Giulio Rossi, et al.
The Annals of Thoracic Surgery|February 27, 2013
Recurrence of thymoma in the right atrium arising from the coronary sinusSalma El Batti, Olaf Mercier, Adela Rohnean, et al.
European Radiology|April 24, 2020
Association of metastatic pattern and molecular status in stage IV non-small cell lung cancer adenocarcinomaAlison Dormieux, Laura Mezquita, Paul Henry Cournede, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2026
Retreatment with First-Generation Selective RET Inhibitors in RET-Rearranged NSCLC Pretreated with Selpercatinib or Pralsetinib - Results from the RET-MAP RegistryArianna Marinello, Julia K Rotow, Meghanne Lomibao, et al.
Frontiers in Oncology|June 28, 2021
Durable Response to the Combination of Atezolizumab With Platinum-Based Chemotherapy in an Untreated Non-Smoking Lung Adenocarcinoma Patient With <i>BRAF</i> V600E Mutation: A Case ReportXiaomin Niu, Yingjia Sun, David Planchard, et al.
Pageof 59